MICROVASCULAR DAMAGE IN THROMBOTIC THROMBOCYTOPENIC PURPURA (MITHO)
STUDY OF MICROVASCULAR DAMAGE IN PATIENTS WITH THROMBOTIC THROMBOCYTOPENIC PURPURA
The goal of this interventional, non-pharmacological clinical study is to assess microcirculatory dysfunction in patients with thrombotic thrombocytopenic purpura (TTP), both during the acute phase and in remission, compared with the general population.
Microcirculatory damage will be defined as the presence of at least one abnormal instrumental finding among brain magnetic resonance imaging (MRI), optical coherence tomography angiography (OCT-A), and nailfold videocapillaroscopy.
This is a monocentric, national study including two patient cohorts:
Cohort 1: patients enrolled during the acute phase Cohort 2: patients enrolled during remission Participants will be followed for three years with a total of five study visits.
Researchers will not test any drug but will perform detailed clinical, laboratory, and instrumental assessments to evaluate microvascular involvement over time.
Participants will:
- Undergo clinical evaluation, including internal medicine and neurological assessments
- Provide blood and urine samples for laboratory analyses
- Undergo instrumental examinations such as brain MRI, OCT-A, and nailfold videocapillaroscopy
- Receive psychological/neuropsychological evaluations
- Attend follow-up visits over a 3-year period (at baseline, 3 months [cohort 1 only], 12, 24, and 36 months)
調査の概要
状態
介入・治療
- 診断テスト:Factor VIII (FVIII)
- 診断テスト:Von Willebrand factor (VWF) antigen
- 診断テスト:VWF:RCo
- 診断テスト:VWF-propeptide
- 診断テスト:VWF multimers
- 診断テスト:sP-selectin
- 診断テスト:sCD40L
- 診断テスト:F1+2
- 診断テスト:VEGF-A
- 診断テスト:VCAM
- 診断テスト:ICAM
- 診断テスト:IL-1β
- 診断テスト:IL-6
- 診断テスト:PTX3
- 診断テスト:BlyS
- 診断テスト:Neutrophil elastase and myeloperoxidase (NETs) markers
- 診断テスト:soluble C5b-9
- 診断テスト:C5a
- 診断テスト:NFL
- 診断テスト:GFAP
- 遺伝的:Whole exome sequencing - WES
- 診断テスト:Proteomic Analysis
- 診断テスト:evaluation of thrombus formation with Total Thrombus formation Analysis System (T-TAS)
- 診断テスト:Microfluidic Flow Chamber
研究の種類
入学 (推定)
段階
- 適用できない
連絡先と場所
研究場所
-
-
Milano
-
Milan、Milano、イタリア、20122
- Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
-
-
参加基準
適格基準
就学可能な年齢
- 大人
- 高齢者
健康ボランティアの受け入れ
説明
Inclusion Criteria:
- aged ≥18 years
- diagnosis of TTP (either congenital or acquired immune-mediated TTP)
- referred at our hospital (Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, S.C. Medicina - Emostasi e Trombosi)
- providing a signed informed consent
Exclusion Criteria:
- Patients who do not possess the above inclusion criteria
- Patients who have known contraindications to the instrumental exam included in the study.
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:診断
- 割り当て:非ランダム化
- 介入モデル:並列代入
- マスキング:なし(オープンラベル)
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
他の:Acute TTP
Patients enrolled during acute phase (cohort 1), T0= within 15 days from hospital admission.
|
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
|
|
他の:Remission TTP
Patients enrolled during clinical remission (cohort 2), T0= check-up visit performed at more than 3 months from clinical response of the previous episode
|
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
|
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Prevalence
時間枠:From enrollment to the last visit (after 36 months from Time 0)
|
Prevalence of microcirculation damage in iTTP patients compared to general population
|
From enrollment to the last visit (after 36 months from Time 0)
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Cerebral microcirculation lesions
時間枠:From enrollment to the last visit (after 36 months from Time 0)
|
Evaluate cerebral microcirculation lesions (via brain MRI) in both acute and remission phases of TTP to monitor organ damage progression over time
|
From enrollment to the last visit (after 36 months from Time 0)
|
|
Retinal microcirculation changes
時間枠:From enrollment to the last visit (after 36 months from Time 0)
|
Assess retinal microcirculation changes (using OCT and OCT-A) during acute and remission phases of TTP to track organ damage evolution
|
From enrollment to the last visit (after 36 months from Time 0)
|
|
Peripheral microcirculation
時間枠:From enrollment to the last visit (after 36 months from Time 0)
|
Analyze peripheral microcirculation (with nailfold videocapillaroscopy) in acute and remission phases to evaluate progression of organ involvement in TTP
|
From enrollment to the last visit (after 36 months from Time 0)
|
|
Association between cerebral MRI lesions and cognitive or psychological symptoms
時間枠:From enrollment to the last visit (36 months from Time 0)
|
Explore the relationship between cerebral MRI lesions and cognitive or psychological symptoms during TTP remission, assessing symptom progression
|
From enrollment to the last visit (36 months from Time 0)
|
|
Modification of preclinical biomarkers
時間枠:From enrollment to the last visit (36 months from Time 0)
|
Explore the modification of preclinical biomarkers over time at different stage of the disease
|
From enrollment to the last visit (36 months from Time 0)
|
|
Associations between preclinical biomarkers and microcirculatory damage
時間枠:From enrollment to the last visit (36 months from Time 0)
|
Identify associations between preclinical biomarkers and microcirculatory damage in both acute and remission phases of TTP to predict risk and progression
|
From enrollment to the last visit (36 months from Time 0)
|
協力者と研究者
研究記録日
主要日程の研究
研究開始 (実際)
一次修了 (推定)
研究の完了 (推定)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
追加の関連 MeSH 用語
その他の研究ID番号
- IRCCSMaggioreH (IRCCSMaggioreH)
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。
Factor VIII (FVIII)の臨床試験
-
Hoffmann-La Roche募集フォン・ヴィレブランド病、3型アメリカ, カナダ, ベルギー, スペイン, ドイツ, 日本, オランダ, イギリス, フランス, ポーランド, 南アフリカ, イタリア, コロンビア, スウェーデン
-
Bayer完了血友病Aドイツ, スペイン, オーストリア, イタリア, スロベニア, ギリシャ, オランダ
-
Bayer完了血友病Aアメリカ, ブルガリア, ルーマニア, アルゼンチン
-
Hoffmann-La RocheChugai Pharmaceutical完了血友病Aオーストラリア, 台湾, 大韓民国, フランス, ドイツ, イタリア, 南アフリカ, スペイン, アメリカ, 日本, アイルランド, ポーランド, イギリス, コスタリカ